Flash Alert: Sell These Two Plays ASAP
When a biotech company reports strong clinical results for a therapy in development, prices can soar. But when an experimental drug fails to clear the bar, prices can move sharply the other way. Today we have two plays we’re exiting ASAP to free up our portfolio for better future opportunities. Plus, one play that’s at a great value right now!
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.